NJ resumes use of J&J vaccine after pause lifted

The CDC determined the benefits of the vaccine outweigh the risks.

Video Transcript

- Now in the race to vaccinate, Johnson & Johnson, getting the green light from federal officials just over a week after it was paused. Now, states are planning on how they're going to roll these doses back out. Eyewitness News reporter, Marcus Solis, live in Hoboken, where New Jersey officials are planning to restart their shots. Marcus.

MARCUS SOLIS: [? And ?] [? like ?] the CDC, determining that the benefits of the Johnson & Johnson vaccine greatly outweigh those risks. And so the green light has been given to resume administering that vaccine. And not long after that, New Jersey alerted the providers that they should also be ready to resume administering the J&J shot.

JANET WOODCOCK: After an extensive review of the available data, the FDA and CDC are lifting the recommended pause on the Johnson & Johnson or Janssen COVID-19 vaccine.

MARCUS SOLIS: Citing an urgent need to vaccinate the country quickly, a CDC advisory panel is recommending the nation resume injections of the Johnson & Johnson one shot vaccine with an updated sheet, warning of the potential for extremely rare-- but serious-- blood clots.

ROCHELLE WALENSKY: With these actions, the administration of Johnson & Johnson's COVID-19 vaccine can resume immediately.

MARCUS SOLIS: Health officials put a pause on using the vaccine after six women developed severe blood clots two weeks after getting the shot. The CDC says there are now 15 of these cases, most of them with severe blood clots near the brain. All of them are women between 18 and 59 years old.

Three have died. And seven are still hospitalized. But health officials underline that these are out of 8 million Americans, who have gotten the shot with no serious complications.

ANTHONY FAUCI: Remember, this is a very rare complication-- a very rare adverse event.

MARCUS SOLIS: Meantime, fewer Americans are getting their COVID-19 vaccine. The daily average of shots is now below three million a day for the first time in weeks.

Scientists have put together this map. The areas in darker blue show where Americans are resisting the vaccine the most. The country's seven day average of daily cases is now 62,500-- roughly 10% lower than last week. But at least seven states have seen an increase in new cases over 10%.

And the CDC anticipates there will be additional clotting issues. But they say, better awareness of the symptoms-- severe head or leg pain-- could mean quicker treatment, minimizing the effects.